TRIPLIXAM Trademark

Trademark Overview

On Tuesday, November 6, 2018, a trademark application was filed for TRIPLIXAM with the United States Patent and Trademark Office. The USPTO has given the TRIPLIXAM trademark a serial number of 88183716. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 6, 2022. This trademark is owned by BIOFARMA. The TRIPLIXAM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of disorders of the cardiovascular system
triplixam

General Information

Serial Number88183716
Word MarkTRIPLIXAM
Filing DateTuesday, November 6, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of disorders of the cardiovascular system
Translation of Words in MarkThe wording "TRIPLIXAM" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 29, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuresnes Cedex 92284
FR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSuresnes Cedex 92284
FR

Trademark Events

Event DateEvent Description
Monday, June 6, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 6, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 5, 2021SOU EXTENSION 5 GRANTED
Wednesday, September 29, 2021SOU EXTENSION 5 FILED
Wednesday, September 29, 2021TEAS EXTENSION RECEIVED
Wednesday, April 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 5, 2021SOU EXTENSION 4 GRANTED
Monday, April 5, 2021SOU EXTENSION 4 FILED
Monday, April 5, 2021TEAS EXTENSION RECEIVED
Friday, September 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 23, 2020SOU EXTENSION 3 GRANTED
Wednesday, September 23, 2020SOU EXTENSION 3 FILED
Wednesday, September 23, 2020TEAS EXTENSION RECEIVED
Wednesday, April 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 20, 2020SOU EXTENSION 2 GRANTED
Monday, April 20, 2020SOU EXTENSION 2 FILED
Monday, April 20, 2020TEAS EXTENSION RECEIVED
Wednesday, August 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 27, 2019SOU EXTENSION 1 GRANTED
Tuesday, August 20, 2019SOU EXTENSION 1 FILED
Tuesday, August 27, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, August 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 20, 2019TEAS EXTENSION RECEIVED
Wednesday, August 7, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 17, 2019ASSIGNED TO EXAMINER
Thursday, November 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 9, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

triplixam disorders cardiovascular system treatment prevention preparations human pharmaceutical